SCHEMBL6771222

SCHEMBL6771222

CC1CC(=O)c2c(C3CC3)nn(-c3cccc(Cl)c3)c2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.47
SRC P12931 2/20 0.44
DRD2 P14416 2/20 0.38
DRD3 P35462 2/20 0.38
KCNH2 Q12809 2/20 0.38
GRM5 P41594 1/20 0.36
CSNK2A2 P19784 2/20 0.36
CSNK2B P67870 2/20 0.36
CSNK2A1 P68400 2/20 0.36
ABCG2 Q9UNQ0 2/20 0.36
CSNK2A3 Q8NEV1 1/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALOX5 P09917 1/20 0.36
CNR1 P21554 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168193 0.86 ABCG2 (0.42) OPRM1CSNK2A2CSNK2BCSNK2A1ABCG2
SCHEMBL6772323 0.86 GPBAR1 (0.41) OPRM1SRCKMT2AALDH1A1MEN1
SCHEMBL6777711 0.85 OPRM1 (0.45) OPRM1SRCDRD2DRD3KCNH2
SCHEMBL6770751 0.85 OPRM1 (0.45) OPRM1SRCKMT2AALDH1A1MEN1
SCHEMBL6770768 0.82 SRC (0.41) OPRM1SRCDRD2DRD3KCNH2
SCHEMBL6770441 0.82 SRC (0.41) SRCDRD2DRD3KCNH2GRM5
SCHEMBL6771814 0.81 SRC (0.60) OPRM1SRCKMT2AALDH1A1MAPK1
SCHEMBL6771042 0.81 ALDH1A1 (0.44) SRCDRD2DRD3KCNH2CSNK2A2
SCHEMBL6767529 0.80 OPRM1 (0.72) OPRM1SRCKMT2AALDH1A1MEN1
SCHEMBL6769517 0.80 SRC (0.39) SRCDRD2DRD3KCNH2GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed